Pendal Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $631K | Sell |
8,767
-4,221
| -32% | -$304K | 0.01% | 345 |
|
|
2022
Q3 | $924K | Buy |
12,988
+344
| +3% | +$24.5K | 0.01% | 284 |
|
|
2022
Q2 | $974K | Sell |
12,644
-24,628
| -66% | -$1.9M | 0.01% | 279 |
|
|
2022
Q1 | $2.72M | Hold |
37,272
| – | – | 0.02% | 211 |
|
|
2021
Q4 | $2.32M | Buy |
+37,272
| New | +$2.32M | 0.02% | 226 |
|
|
2021
Q3 | – | Sell |
-15,829
| Closed | -$1.06M | – | 577 |
|
|
2021
Q2 | $1.06M | Sell |
15,829
-11,944
| -43% | -$798K | 0.01% | 332 |
|
|
2021
Q1 | $1.75M | Sell |
27,773
-6,406
| -19% | -$404K | 0.02% | 240 |
|
|
2020
Q4 | $2.12M | Sell |
34,179
-25,512
| -43% | -$1.58M | 0.02% | 211 |
|
|
2020
Q3 | $3.6M | Buy |
59,691
+32,877
| +123% | +$1.98M | 0.04% | 121 |
|
|
2020
Q2 | $1.58M | Buy |
26,814
+10,910
| +69% | +$642K | 0.02% | 200 |
|
|
2020
Q1 | $886K | Sell |
15,904
-47,174
| -75% | -$2.63M | 0.02% | 225 |
|
|
2019
Q4 | $4.05M | Buy |
63,078
+59,692
| +1,763% | +$3.83M | 0.05% | 148 |
|
|
2019
Q3 | $172K | Sell |
3,386
-223,613
| -99% | -$11.3M | ﹤0.01% | 419 |
|
|
2019
Q2 | $10.3M | Sell |
226,999
-142,040
| -38% | -$6.44M | 0.14% | 72 |
|
|
2019
Q1 | $17.6M | Buy |
369,039
+25,920
| +8% | +$1.24M | 0.24% | 61 |
|
|
2018
Q4 | $17.8M | Buy |
343,119
+166,187
| +94% | +$8.64M | 0.28% | 60 |
|
|
2018
Q3 | $11M | Sell |
176,932
-60,916
| -26% | -$3.78M | 0.15% | 84 |
|
|
2018
Q2 | $13.2M | Buy |
237,848
+43,663
| +22% | +$2.42M | 0.17% | 91 |
|
|
2018
Q1 | $12.3M | Sell |
194,185
-19,720
| -9% | -$1.25M | 0.16% | 89 |
|
|
2017
Q4 | $13.1M | Buy |
213,905
+49,551
| +30% | +$3.04M | 0.17% | 94 |
|
|
2017
Q3 | $10.5M | Buy |
164,354
+56,032
| +52% | +$3.58M | 0.14% | 118 |
|
|
2017
Q2 | $6.04M | Buy |
+108,322
| New | +$6.04M | 0.09% | 154 |
|